Đang chuẩn bị nút TẢI XUỐNG, xin hãy chờ
Tải xuống
Tuyển tập các báo cáo nghiên cứu về y học được đăng trên tạp chí y học Minireview cung cấp cho các bạn kiến thức về ngành y đề tài: A model worth considering? | Comment A model worth considering Gregory A Petsko Address Rosenstiel Basic Medical Sciences Research Center Brandeis University Waltham MA 02454-9110 USA. Email petsko@brandeis.edu Published 29 December 2006 Genome Biology 2006 7 121 doi l0.ll86 gb-2006-7-l2-l2l The electronic version of this article is the complete one and can be found online at http genomebiology.com 2006 7 l2 l2l 2006 BioMed Central Ltd I d like to introduce you to Scott Johnson who thinks he has a better way of translating basic research discoveries into therapies for human diseases. Like many of the other people who have made a difference in the battle to cure diseases that pharmaceutical companies and governments have largely ignored - for example the actor Michael J Fox in the case of Parkinson s disease and the financier Michael Milken in the case of prostate cancer - Mr Johnson has a very personal reason for wanting to see a particular disease cured. In 1976 when he was 20 years old Scott Johnson was diagnosed with multiple sclerosis. He s 50 now and he knows that without a cure his life expectancy is predicted to be about 7 years less than the average for a healthy adult. But that isn t the main reason that Scott Johnson is a man in a hurry. He s in a hurry because he thinks he s figured it out and when you think you ve figured it out you re naturally anxious to see if you re right. Based on his track record it might be unwise to bet against him. Multiple sclerosis didn t prevent him from a successful business career with the Boston Consulting Group and several Silicon Valley startups. That wouldn t make him the first businessman who thought he could apply the principles of corporate management to a new area government is a favorite one not by any means. But Mr Johnson doesn t want to run a state or even a city. He wants to change the way cures for diseases are found. In 2003 he left business to start the Myelin Repair Foundation. The origins and progression of multiple sclerosis which .
